Common foot examination features of 247 Iranian patients with diabetes

International Wound Journal

Volumn 6, Issue 2, 2009, Pages 117-122

  Alavi, A ^a,b   Sanjari, M ^c   Haghdoost, A ^d   Sibbald, R G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Afzal Research Center   (Iran)

^c Physiology Research Center   (Iran)

^d SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Case studies; Diabetic foot ulcer; Iran; Prospective; Wound

Indexed keywords

ADULT; AGED; ARTICLE; CALLUS; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; FOOT AMPUTATION; HAMMER TOE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SKIN FISSURE; TIBIALIS POSTERIOR MUSCLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HAMMER TOE SYNDROME; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 65349166656     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2009.00583.x     Document Type: Article

References (20)

1. Inlow S, Orsted H, Sibbald RG. Best practices for the prevention, Diagnosis and treatment of diabetic foot ulcers. Ostomy Wound Manage 2000 46 : 55 68.
2. International Diabetes Federation. Diabetes Atlas available at http://idf.firstserved.net/staging/atlas.html.
3. Eldor R, Raz I, Yehuda AB, Boulton JM. New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies. Diabet Med 2004 21 : 1161 73.
4. Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet 2003 361 : 1545 51.
5. Boulton A, Vileikyte L, Tennvall GR, Apelquit J. The global burden of diabetic foot disease. Lancet 2005 366 : 1719 24.
6. Wu S, Armstrong DG. Risk assessment of diabetic foot and wound. Int Wound J 2005 2 : 17 24.
7. Houton WH. Barriers to the delivery of diabetic foot care. 2005 360 : 1678 9, www.thelancet.com.
8. Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. Screening for type 2 diabetes in the Iranian national program: a preliminary report. East Mediterr Health J 2003 9 : 1122 6.
9. Azizi F, Rahmani M, Habib E. Tehran lipid and glucose study (TLGS): rationale and design. CVD Prev 2000 3 : 242 7.
10. Larijani B, Zahedi F, Aghakhani SH. Epidemiology of diabetes mellitus in Iran. Shiraz E-med J 2003 4.
11. Amini M, Afshin-Nia F, Bashardoost N, Aminorroaya A, Shahparian M, Kazemi M. Prevalence and risk factors of diabetes mellitus in the Isfahan city population (aged 40 or over) in 1993. Diabetes Res Clin Pract 1997 38 : 185 90.
12. Cavanagh PR, Lipsky BA, Bradburg AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005 366 : 1725 35.
13. Rovan VU. Causes of diabetic foot lesions. Lancet 2005 366 : 1675 6.
14. Sibbald RG, Armstrong DG, Orsted H. Pain in diabetic foot ulcers. Ostomy Wound Manage 2003 49 (Suppl 4A 24 9.
15. Reiber GE, Rougi G. Preventing foot ulcers and amputations in diabetes. Lancet 2005 366 : 1766 7.
16. Coutts P, The effects of cultural background on patient communications and adherence to treatment. Wound Care Can 2005 3 : 42 4.
17. Greenman RL, Panasyuk S, Wang X, lyans TE, Dinh T, Longoria L, Giurini JM, Freeman J, Khaodhiar L, Veves A. Early changes in skin microcirculation and muscle metabolism of diabetic foot. Lancet 2005 366 : 1711 7.
18. Osterberg L, Blaschke T. Adherence to medication. N Eng J med 2005 353 : 487 97.
19. Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC neurology 2005 5 : 24.
20. Falanga V. Wound healing and its impairment in diabetic foot ulcer. Lancet 2005 366 : 1736 44.